2009 Harry Hirsch Leiter Award Recipient: Epidemiology of ulcerative keratitis in northern California

• B.H..Jeng,^1,2, D.C. Gritz ^1,2 , A.B. Kumar¹, D.S. Holsclaw^1,4 , T.C. Porco^1,5 , S.D. Smith² , J.P. Whitcher¹ , T.P. Margolis¹ , I.G. Wong^{1,6
  1}F.I. Proctor Foundation and the Department of Ophthalmology, University of California, San Francisco, CA., ² Cole Eye Institute, Cleveland Clinic, Cleveland, OH.,³ Kaiser Permanente Foundation Hospitals-Oakland, Richmond, CA, ⁴ Redwood City, CA, ⁵ Dept. of Epidemiology and Biostatistics, University     of California, San Francisco, CA, ⁶Dept. of Ophthalmology, Stanford Univ., Palo Alto, CA

Trends in pediatric corneal ulcers at the New York Eye and Ear Infirmary

• A. Hong, D. Joshi, A. Djougarian, J Seedor, D Ritterband
  Dept. of Ophthalmology, The New York Eye and Ear Infirmary, New York, NY, Dept. of Ophthalmology, New York Medical College, Valhalla, NY

The steroids for corneal ulcers trial (SCUT) baseline data and Bayesian statistic inquiry

• C.W. See¹, N.R. Acharya¹, M. Srinivasan², M.E. Zegans³, K. Ray¹, D. Glidden⁴, C. Oldenburg¹, T. Porco1,⁴, T.M. Lietman^1,4
  ¹ F.I. Proctor Foundation and the Dept. of Ophthalmology, University of California San Francisco, CA ²Aravind Eye Care System, Madurai, India ³ Dept. of Ophthalmology, Dartmouth Medical School, Lebanon, New Hampshire, DE ⁴ Dept. of Epidemiology and Biostatistics, University of California, San Francisco, CA

Diagnosis, treatment and outcomes of patients with infectious scleritis

• K. H. MD¹, A. Galor MD^1,2, C.L. Karp¹, T.A. Albini¹, V.L. Perez¹,  J. Davis¹, D. Miller¹, R.K. Forster^{1
  1}Bascom Palmer Eye Institute, University of Miami, Miami, FL; ²Miami Veterans Administration Medical Center, Miami FL

Clinical differentiation of bacterial and fungal corneal ulcersFusarium Keratitis Epidemic of 2004-2006.

• C. Dalmon¹,T. Porco¹, T. Lietman¹, L. Prajna², M. Ranjan Das², J.A. Kumar², J. Mascarenhas², T. Margolis¹, J. Whitcher¹, B.H. Jeng¹, J. Keenan¹, M. Chan¹, S. McLeod¹, N.R. Acharya^{1
  1}F. I. Proctor Foundation, University of California, San Francisco, San Francisco, CA, ²Aravind Eye Hospital, Madurai, South India

Confocal interpretation compared with clinical and microbiological findings in atypical keratitis: review of 64 cases

• PB Wall, TF Mauger, RA Kuennen, AJ Hendershot, The Ohio State University Medical Center, Dept. of Ophthalmology, Columbus, OH

Discriminative profile between Acanthamoeba T4 and non-T4 genotypes by 18S rDNA gene fingerprint

• F.R.S. Carvalho, A.S.  Foronda, D. de Freitas, Federal University of Sao Paulo, Dept. of Ophthalmology

Acanthamoebal and stenotrophomonas maltophilia keratitis with fungal keratitis in the contralateral eye

• W.I. Sawyer, R.A. Kuennen, R. Harder-Smith, T.F. Mauger, Havener Eye Institute, The Ohio State University, Columbus, OH

Endophthalmitis caused by enterococcus faecalis after intravitreal injection of bevacizumab

• S. Kobayakawa, K. Kakisu, A. Kanayama, I. Kobayashi, T. Tochikubo, The Dept. of Ophthalmology, Toho University, Tokyo, Japan

In-vitro susceptibility profile of ceftobiprole against MRSA isolates

• J. Kuryan, M. Shah, W. Perez, A. Jangi, E. Wu, J. Seedor, D. Ritterband, Depts. of Ophthalmology and Laboratory Medicine, The New York Eye and Ear Infirmary, NY, NY and New York Medical College, Valhalla, NY.

Prophylactic treatment with vigazera, zymar, or zymaxid of staphylococcus aureus infections in the rabbit anterior chamber

• C.L. Balzli, A.C. Weeks, R.W. Besinger, C.A. Richmond, R.J. O’Callaghan, University of Mississippi Medical Center Dept. of Microbiology, Jackson, MS.

Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures

• N.R. Acharya¹, R.E. Fintelmann¹, E.N. Hoskins¹, J.D. Keenan¹, B.D. Gaynor¹, V. Cevallos¹, T.M. Lietman^{1,2
  1}F.I. Proctor Foundation and Dept. of Ophthalmology, University of California, San Francisco, CA, ²Dept. of Epidemiology & Biostatistics, University of California, San Francisco, CA

A comparison of the in vitro susceptibility profiles of telavancin, vancomycin, moxifloxacin and gatifloxacin against gram positive keratitis isolates including methicillin resistant staphylococcus aureus (MRSA)

• M. Shah, W. Perez, E. Wu, J. Seedor, R. Koplin, D. Ritterband,  Depts. of Ophthalmology and Laboratory Medicine, The New York Eye and Ear Infirmary, NY, NY and New York Medical College, Valhalla, NY

Intrastromal versus topical moxifloxacin in a rabbit model of pseudomonas aeruginosa keratitis

• T. Chan, J.I. Stuart, L. Allen, R. Mather, Ivey Eye Institute, University of Western Ontario, London, Ontario, Canada

Exophiala jeanselmei keratitis: case report and review of literature

• O.J. Saeedi, S. Iyer, R. N. Hogan, Dept. of Ophthalmology, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX

Metarrhizium anisopliae keratitis

• H. Ahmadi, D.G. Heidemann, S.P. Dunn, C. Y. C. Chow, Oakland University - William Beaumont Hospital, Royal Oak, MI

New bugs and a new treatment for giant fornix syndrome

• J.B. Taylor,¹ R.E. Fintelmann,^1,2 E.Y. Tu,³ B.H Jeng^{1,2 
  1}Dept. of Ophthalmology and ²Francis I. Proctor Foundation, University of California San Francisco, CA, and ³Dept. of Ophthalmology University of Illinois Chicago, IL

Validation of PCR for the detection of pseudomonas aeruginosa from cornea specimens

• R. P. Kowalski, M.A. Hillenbrand, E.G. Romanowski, P.P. Thompson, The Charles T. Campbell Ophthalmic Microbiology Laboratory, The University of Pittsburgh, Pittsburgh, PA

BSS Plus® can alter the antimicrobial activity of human lysozyme against S. epidermidis

• K.E. Griswold¹, H.L. Jewell¹, M.E. Zegans^{2
  1}Thayer School of Engineering, Dartmouth College, ²Dept. of Microbiology and Immunology, Dept. of Surgery (Ophthalmology), Dartmouth Medical School, Hanover, NH

Cell-associated protection assay (CAPA) demonstrates antibiotic protection of ocular surface cell lines against clinical S. aureus even after all free antibiotic is removed from the culture medium

• J.B. Wingard, E.G. Romanowski, R.P. Kowalski, F.S. Mah, Y.J. Gordon, R.M.Q. Shanks, The Charles T. Campbell Laboratory, UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA

The role of atopy in penetrating corneal graft survival and rejection in keratoconus

• J.K. Thomas, A. Guel, H.D. Cavanagh, University of Texas Southwestern Medical Center at Dallas,   Dept. of Ophthalmology, Dallas, TX

Thygeson’s superficial puncate keratitis and scarring.

• R.E. Fintelmann, M.M. Bloomer, T.P. Margolis, Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA

Ophthalmic manifestations of human immunodeficiency virus infection in the era of highly active antiretroviral therapy

• R. Sorenson¹, B.H. Jeng^{1,2
  1}Dept. of Ophthalmology, University of California San Francisco and San Francisco General Hospital, San Francisco, CA, ²Francis I. Proctor Foundation, University of California San Francisco, CA

10:39 am

In Vivo confocal microscopy reveals bilateral increase in epithelial dendritic cell density correlating with the diminishment of subbasal nerve plexus in patients with unilateral herpes simplex keratitis

• Cruzat,¹ D. Witkin,¹ N. Baniasadi,¹ L. Zheng,² D. Pavan-Langston,¹ P. Hamrah.^{1,2  
   1}Cornea Service and Ocular Surface Imaging Center, Massachusetts Eye & Ear Infirmary, Dept. of Ophthalmology, Boston, MA, ² Immune Disease Institute, Harvard Medical School, Boston, MA

15th Thygeson Lecture: The Varicella Zoster Virus ‑ Translating research in other medical fields to ophthalmology

• Thomas J. Liesegang, M.D.,
  Professor of Ophthalmology, Mayo Clinic, FL

Closing Comments and Awards

12:00 pm